drugset / Trial / NCT00693589
Effect of Homocysteine-lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Endothelial dysfunction is an early marker of atherosclerosis and is found in patients (pts) with coronary (CAD) and peripheral artery disease (PAD). Statin-therapy has been shown to improve endothelial function in pts with CAD or PAD by reducing LDL-cholesterol and inflammatory markers. B-group vitamin-supplements have variable been reported to have positive or neutral effects on endothelial function. Therefore, we want to compare the effect of rosuvastatin and B-group vitamin supplementation on endothelial function of the forearm resistance vessels in pts with cardiovascular disease.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-02
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | B6 | Other / unclassified | 10 mg | Oral |
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Vitamin B12 | Other / unclassified | 0.4 mg | Oral |
| Comparator | folic acid | Other / unclassified | 1 mg | Oral |